 "Intraday trading strategies by Geojit BNP Paribas")
HDFC BANK (Rs 1007.20)
Support at Rs 994 below Rs 989. Resistance is at Rs 1015 above Rs 1030. (Buy for intraday with a stoploss below Rs989)
[MACD & STOCHASTICS BUY + ABV PREVIOUS CLOSE + VOLUME JUMP]
SUVEN LIFE SCIENCES (Rs 201.90)
Support at Rs198.70 below Rs 196.20. Resistance is at Rs 204.75 above Rs 207. (Buy for intraday with a stoploss below Rs 196.20)
[MACD & STOCHASTICS BUY + VOLUME JUMP + ABV PREVIOUS CLOSE]
SAREGAMA INDIA (Rs 266.45)
Support at Rs 260 below Rs 259.10. Resistance is at Rs 270.50 above Rs 273.35. (Buy for intraday with a stoploss below Rs 259.10)
[MACD & STOCHASTICS BUY+ ABV PREVIOUS CLOSE + VOLUME JUMP]
NCC (Rs 69.45)
Support at Rs 68.10 below Rs 67.20. Resistance is at Rs 71.55 above Rs 73.05. (Buy for intraday with a stoploss below Rs 67.20)
[ABV PREVIOUS CLOSE+ VOLUME JUMP + MACD & STOCHASTICS BUY + ABV 50 DMA]
TATA CONSULTANCY SERVICES (Rs 2318.85)
Support at Rs 2305 below Rs 2285. Resistance is at Rs 2342 above Rs 2365. (Buy for intraday with a stoploss below Rs 2285)
[STOCHASTICS BUY+ ABV PREVIOUS CLOSE + VOLUME BUILD UP]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
Support at Rs 994 below Rs 989. Resistance is at Rs 1015 above Rs 1030. (Buy for intraday with a stoploss below Rs989)
Read more from our special coverage on "TECHNICAL CALLS"
[MACD & STOCHASTICS BUY + ABV PREVIOUS CLOSE + VOLUME JUMP]
SUVEN LIFE SCIENCES (Rs 201.90)
Support at Rs198.70 below Rs 196.20. Resistance is at Rs 204.75 above Rs 207. (Buy for intraday with a stoploss below Rs 196.20)
[MACD & STOCHASTICS BUY + VOLUME JUMP + ABV PREVIOUS CLOSE]
SAREGAMA INDIA (Rs 266.45)
Support at Rs 260 below Rs 259.10. Resistance is at Rs 270.50 above Rs 273.35. (Buy for intraday with a stoploss below Rs 259.10)
[MACD & STOCHASTICS BUY+ ABV PREVIOUS CLOSE + VOLUME JUMP]
NCC (Rs 69.45)
Support at Rs 68.10 below Rs 67.20. Resistance is at Rs 71.55 above Rs 73.05. (Buy for intraday with a stoploss below Rs 67.20)
[ABV PREVIOUS CLOSE+ VOLUME JUMP + MACD & STOCHASTICS BUY + ABV 50 DMA]
TATA CONSULTANCY SERVICES (Rs 2318.85)
Support at Rs 2305 below Rs 2285. Resistance is at Rs 2342 above Rs 2365. (Buy for intraday with a stoploss below Rs 2285)
[STOCHASTICS BUY+ ABV PREVIOUS CLOSE + VOLUME BUILD UP]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.